Effect of calcium antagonists on thyrotropin and thyroid hormone secretion.

Endokrinologie Pub Date : 1982-10-01
I Zofková, J Blahos, J Bednár
{"title":"Effect of calcium antagonists on thyrotropin and thyroid hormone secretion.","authors":"I Zofková,&nbsp;J Blahos,&nbsp;J Bednár","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The authors investigated the effect of one-week administration of verapamil in daily therapeutic doses of 4 X 40 mg by the oral route and the effect of nifedipine in daily therapeutic doses of 3 X 20 mg by the oral route. Verapamil and nifedipine did not affect significantly the levels of thyrotropin, triiodothyronine and thyroxine nor their response after stimulation with TRH. The theoretical and practical impact of this finding is discussed in particular with regard to possible side-effects of calcium antagonists during their therapeutic use in clinical cardiology.</p>","PeriodicalId":11605,"journal":{"name":"Endokrinologie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1982-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endokrinologie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The authors investigated the effect of one-week administration of verapamil in daily therapeutic doses of 4 X 40 mg by the oral route and the effect of nifedipine in daily therapeutic doses of 3 X 20 mg by the oral route. Verapamil and nifedipine did not affect significantly the levels of thyrotropin, triiodothyronine and thyroxine nor their response after stimulation with TRH. The theoretical and practical impact of this finding is discussed in particular with regard to possible side-effects of calcium antagonists during their therapeutic use in clinical cardiology.

钙拮抗剂对促甲状腺素和甲状腺激素分泌的影响。
作者研究了维拉帕米1周每日4 × 40 mg的口服治疗效果和硝苯地平每日3 × 20 mg的口服治疗效果。维拉帕米和硝苯地平不显著影响促甲状腺素、三碘甲状腺原氨酸和甲状腺素的水平,也不显著影响TRH刺激后的反应。这一发现的理论和实际影响被讨论,特别是关于钙拮抗剂在临床心脏病学治疗中可能产生的副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信